Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -164.32% is in line with its 1-year average of -160.94%, around the middle of its 1-year range (-323.59%–-69.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.78% below its 12-month average of -155.34%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -164.32%.
RETURN ON INVESTED CAPITAL (ROIC)
-164.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-155.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.78%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 547 covered companies
CURRENT VS SECTOR MEDIAN
-419.67%
vs the sector median at left
CapsoVision, Inc.
Market Cap
$323.01M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-155.34%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$328.40M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$329.37M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$316.53M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
Market Cap
$309.45M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$304.88M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
Market Cap
$341.46M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$341.50M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$348.55M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $323.01M | -164.32% | -155.34% | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $328.40M | -35.92% | -35.67% | -36.59% | -30.23% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -85.56% | -114.55% | -77.72% | -63.50% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $316.53M | -122.21% | -122.21% | -122.21% | -122.21% |
| Standard BioTools Inc. (LAB)vs › | $309.45M | -14.06% | -26.07% | -28.37% | -26.89% |
| Benitec Biopharma Inc. (BNTC)vs › | $304.88M | -28.88% | -35.80% | -1011.32% | -772.02% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $341.46M | -40.51% | -48.13% | -48.38% | -39.85% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.50M | -27.16% | -54.52% | -49.44% | -51.83% |
| Agenus Inc. (AGEN)vs › | $348.55M | N/A | -35.18% | -129.73% | -103.61% |
| Embecta Corp. (EMBC)vs › | $354.48M | 17.99% | 23.20% | 26.35% | 40.47% |
ROIC
-164.3%
ROE
-226.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -164.32% |
| 2026-03-31 | -92.84% |
| 2025-12-31 | -126.64% |
| 2025-09-30 | -69.29% |
| 2025-06-30 | -323.59% |
| 2025-03-31 | -217.11% |
| 2024-12-31 | -132.77% |
